Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
2.020
+0.200 (10.99%)
At close: May 22, 2026, 4:00 PM EDT
2.090
+0.070 (3.47%)
After-hours: May 22, 2026, 7:11 PM EDT
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $14.54 million as of May 22, 2026. Its market cap has decreased by -37.29% in one year.
Market Cap
14.54M
Enterprise Value
6.50M
1-Year Change
-37.29%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $14.54M, a decrease of -97.70%. That is a compound annual growth rate of -51.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 14.54M | 43.21% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cadrenal Therapeutics | 15.98M |
| GT Biopharma | 15.87M |
| Cocrystal Pharma | 15.86M |
| Vyome Holdings | 15.65M |
| SeaStar Medical Holding | 14.99M |
| Theriva Biologics | 14.41M |
| Ernexa Therapeutics | 13.98M |
| Genenta Science | 13.68M |